FDA — authorised 25 March 2003
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: approved
🇺🇸 Trovert in United States
FDA authorised Trovert on 25 March 2003
Marketing authorisations
FDA — authorised 26 September 2013
- Application: BLA021106
- Marketing authorisation holder: PHARMACIA
- Indication: Manufacturing (CMC)
- Status: approved
Trovert in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Trovert approved in United States?
Yes. FDA authorised it on 25 March 2003; FDA authorised it on 26 September 2013.
Who is the marketing authorisation holder for Trovert in United States?
PHARMACIA AND UPJOHN holds the US marketing authorisation.